Form 4: Scholar Rock CSO Exercises Options, Sells Shares

Scholar Rock Holding Corp's Chief Scientific Officer, Mo Qatanani, exercised multiple stock options and subsequently sold a portion of the acquired common stock under a pre-arranged 10b5-1 trading plan.

Summary

• Mo Qatanani, Chief Scientific Officer of Scholar Rock Holding Corp (SRRK), executed multiple transactions on January 14, 2026.
• These transactions were conducted pursuant to a Rule 10b5-1 trading plan adopted on March 31, 2025.
• Qatanani exercised stock options to acquire a total of 13,112 shares of common stock at various exercise prices ranging from $7.62 to $35.15.
• Concurrently, Qatanani disposed of 13,112 shares of common stock at a weighted average price of $45.1961 per share, with individual sales ranging from $45.00 to $45.45.
• Following these transactions, Qatanani's direct beneficial ownership of common stock is 108,964 shares, consisting entirely of Restricted Stock Units (RSUs).
• Several stock options remain unvested, with shares totaling 961, 11,250, 47,143, and 32,142, subject to future quarterly vesting installments contingent on continued service.

Sentiment

Score: 6

Explanation: The filing reports routine insider transactions (option exercises and sales) executed under a pre-established 10b5-1 trading plan, which is generally considered neutral. The insider realized a profit from exercising options and selling shares, which is positive for the individual.

Positives

• The insider realized a significant profit by exercising options at lower prices and selling shares at a weighted average price of $45.1961.
• The transactions were executed under a Rule 10b5-1 trading plan, indicating pre-planned activity and reducing concerns about opportunistic timing.

Negatives

• An insider selling shares, even under a 10b5-1 plan, can sometimes be perceived negatively by the market, although it is often for personal financial planning.
• The direct common stock holdings of the Chief Scientific Officer were reduced by 13,112 shares following these transactions.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: May view insider selling as a slight negative, but the execution under a 10b5-1 plan mitigates concerns about opportunistic timing. The company's underlying value is not directly impacted by this transaction.

Next Steps

• Continued vesting of remaining stock options in quarterly installments, contingent on the reporting person's service relationship with the Issuer.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions (option exercises and subsequent sales) executed under a pre-established 10b5-1 trading plan. Such transactions are typically for personal financial management and do not inherently signal a change in the company's fundamental outlook or performance. While an insider sale might sometimes raise questions, the existence of a 10b5-1 plan mitigates concerns about opportunistic timing. Therefore, this filing alone does not provide sufficient new information to warrant a change from a 'hold' recommendation. Investors should continue to evaluate the company based on its operational performance, pipeline developments, and broader market conditions.

Keywords

Scholar Rock, SRRK, insider trading, Form 4, stock options, 10b5-1 plan, Chief Scientific Officer, equity transactions